Chronic Spontaneous Urticaria (CSU)Symptoms, Doctors, Treatments, Advances & More
Learn About Chronic Spontaneous Urticaria (CSU)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Endeavor Health Medical Group
Giselle Mosnaim, MD, an allergist and immunologist at Endeavor Health, treats conditions such as asthma, allergic rhinitis, eczema and chronic hives. Drawing from her personal and family experience with allergies, she offers compassionate, evidence-based care tailored to each patient's lifestyle. In addition to seeing patients, Dr. Mosnaim leads clinical research on biologics and digital tools for allergy and asthma treatment. Dr. Mosnaim is rated as an Elite provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Chronic Spontaneous Urticaria (CSU), Asthma, Hives, and Vibratory Urticaria. Dr. Mosnaim is board certified in American Board Of Allergy Immunology.
The Milton S. Hershey Medical Center
Jonathan Bernstein is a Hematologist and an Oncologist practicing medicine in Hershey, Pennsylvania. Dr. Bernstein is rated as an Elite provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Chronic Spontaneous Urticaria (CSU), Hemophilia A, Mast Cell Activation Syndrome (MCAS), and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).
Office
Thomas Casale is an Internal Medicine provider practicing medicine in Omaha, Nebraska. Dr. Casale is rated as an Elite provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Asthma, Hives, Chronic Spontaneous Urticaria (CSU), and Allergic Rhinitis.
Summary: This study aims to evaluate the efficacy and safety of lesigercept in approximately 150 participants with CSU. By enrolling participants with an inadequate response to H1-antihistamines, including those previously treated with omalizumab, this study is expected to provide evidence for the clinical utility of lesigercept and to further characterize its benefit-risk profile in the target participant...
Summary: The purpose of this trial is: 1. to assess the efficacy, pharmacokinetics, and safety of remibrutinib vs. placebo in adolescents from 12 to \< 18 years of age suffering from chronic spontaneous urticaria inadequately controlled by H1-antihistamines 2. to collect long-term efficacy, safety and tolerability data on remibrutinib in adolescents after having completed 24 weeks of treatment 3. to collec...